Equity Overview
Price & Market Data
Price: $0.0304
Daily Change: $0.00 / 0.00%
Daily Range: $0 - $0
Market Cap: $5,141,529
Daily Volume: 0
Performance Metrics
1 Week: 128.6%
1 Month: 128.6%
3 Months: 128.6%
6 Months: 128.6%
1 Year: 128.6%
YTD: %
Details
Quest PharmaTech Inc., a pharmaceutical company, engages in the development of novel therapeutics for the treatment of targeted cancer. The company's lead product candidate is Mab AR 9.6 against truncated O-glycan on MUC16 for the potential cancer targets, including pancreatic, colon, leukemia, ovarian, and breast cancer. Quest PharmaTech Inc. is headquartered in Edmonton, Canada.